Celyad Oncology SA Performance
Celyad Oncology Relative Risk vs. Return Landscape
If you would invest (100.00) in Celyad Oncology SA on December 19, 2024 and sell it today you would earn a total of 100.00 from holding Celyad Oncology SA or generate -100.0% return on investment over 90 days. Celyad Oncology SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Celyad, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Celyad Oncology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celyad Oncology's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Celyad Oncology SA, and traders can use it to determine the average amount a Celyad Oncology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CYADY |
Based on monthly moving average Celyad Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celyad Oncology by adding Celyad Oncology to a well-diversified portfolio.
Things to note about Celyad Oncology SA performance evaluation
Checking the ongoing alerts about Celyad Oncology for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Celyad Oncology SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celyad Oncology SA is not yet fully synchronised with the market data | |
| Celyad Oncology SA has some characteristics of a very speculative penny stock |
- Analyzing Celyad Oncology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celyad Oncology's stock is overvalued or undervalued compared to its peers.
- Examining Celyad Oncology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celyad Oncology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celyad Oncology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celyad Oncology's pink sheet. These opinions can provide insight into Celyad Oncology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Celyad Pink Sheet
If you are still planning to invest in Celyad Oncology SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad Oncology's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |